Evaluation of the Immune Response against Neisseria meningitidis B:14,P1-7,16 in subjects inoculated by MenBVac (R) vaccine.
Phase of Trial: Phase III
Latest Information Update: 10 Oct 2017
At a glance
- Drugs Meningococcal vaccine group B OMV (Primary)
- Indications Meningococcal group B infections
- Focus Pharmacodynamics
- 10 Oct 2017 New trial record